Q1 2022 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Good afternoon. This is Anna Marie Wagner, SVP of Corporate Development at Ginkgo Bioworks. As usual, I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO. Thanks again for joining us, and we look forward to providing you with an update on our last quarter.
As a reminder, during the presentation today, we'll be making some forward-looking statements, which involve risks and uncertainties. Please refer to our filings with the Securities and Exchange Commission to learn more about these risks and uncertainties.
We'll follow our standard agenda for these calls. We'll provide an update on our financial progress while also taking an opportunity to dive deeper into an area of strategic importance as folks continue to develop a deeper understanding of what we're building. As I said before, if there are topics you'd like to see in a future deep dive, just let us know. We'd love to include those in the future. As usual, we'll end with a Q&A session, and I'll take questions from analysts,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |